Balancing Cancer Immunotherapy Efficacy and Toxicity

Anti–programmed cell death-1 receptor/programmed cell death-1 receptor ligand–directed therapies are transforming cancer care, with durable antitumor responses observed in multiple cancer types. Toxicities arising from therapy are autoimmune in nature and may affect essentially any organ system. The...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Johnson, Douglas B., Jakubovic, Baruch D., Sibaud, Vincent, Sise, Meghan E.
Format: Online Artikel Text
Sprache:English
Veröffentlicht: American Academy of Allergy, Asthma & Immunology 2020
Schlagworte:
Review and Feature Article
Online Zugang:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Online

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318967/
https://www.ncbi.nlm.nih.gov/pubmed/32599218
http://dx.doi.org/10.1016/j.jaip.2020.06.028

Ähnliche Einträge